Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
United Therapeutics Corporation June 26, 202689.3%
-
United Therapeutics Corporation June 26, 202586.8%
-
United Therapeutics Corporation June 26, 202486.7%
-
United Therapeutics Corporation June 26, 202387.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | United Therapeutics Corporation | Option exercise | +1,300 | $119.76 | $155,688 |
| Mar 30, 2026 | United Therapeutics Corporation | Open-market sale | −1,300 | $604.64 | $786,032 |
| Mar 4, 2026 | United Therapeutics Corporation | Option exercise | +20 | $119.76 | $2,395 |
| Mar 4, 2026 | United Therapeutics Corporation | Open-market sale | −20 | $490.17 | $9,803 |
| Feb 25, 2026 | United Therapeutics Corporation | Option exercise | +1,000 | $119.76 | $119,760 |
| Feb 25, 2026 | United Therapeutics Corporation | Open-market sale | −1,000 | $520.00 | $520,000 |
| Jan 6, 2026 | United Therapeutics Corporation | Option exercise | +1,000 | $119.76 | $119,760 |
| Jan 6, 2026 | United Therapeutics Corporation | Open-market sale | −1,000 | $510.00 | $510,000 |
| Jan 2, 2026 | United Therapeutics Corporation | Option exercise | +1,000 | $119.76 | $119,760 |
| Jan 2, 2026 | United Therapeutics Corporation | Open-market sale | −1,000 | $500.01 | $500,010 |
| Nov 3, 2025 | United Therapeutics Corporation | Gift | −450 | — | — |
| Sep 24, 2025 | United Therapeutics Corporation | Option exercise | +1,000 | $119.76 | $119,760 |
| Sep 24, 2025 | United Therapeutics Corporation | Open-market sale | −1,000 | $440.00 | $440,000 |
| Sep 2, 2025 | United Therapeutics Corporation | Option exercise | +3,000 | $132.30 | $396,900 |
| Sep 2, 2025 | United Therapeutics Corporation | Open-market sale | −1,000 | $419.63 | $419,630 |
Questions about Christopher Causey
What boards is Christopher Causey on?
Christopher Causey sits on the board of United Therapeutics Corporation.
How long has Christopher Causey served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.